ÂÜÀòÂÒÂ×

Earl Douglas is a seasoned legal executive with extensive experience in the biotechnology and pharmaceutical sectors. Currently serving as Senior Vice President and General Counsel at Allogene Therapeutics since August 2023, Douglas has previously held significant legal roles at Applied Molecular Transport, Kiverdi, Inc., LevitasBio, and Mesoblast Limited, among others. Their expertise encompasses intellectual property, corporate governance, regulatory compliance, and commercial transactions. Douglas has contributed to the legal strategies of various companies, including overseeing IPO preparations and patent strategies for innovative biotechnological solutions. Douglas holds a Bachelor of Science in Chemical Engineering from the Massachusetts Institute of Technology and a Doctor of Law from Columbia University.